Asthma Therapeutics Market to 2027 - Global Analysis and Forecasts by Product Type (Dry powder inhalers, Metered dose inhalers, Mist inhalers, Nebulizer); Drug Class (Anti-inflammatory drugs, Bronchodilators, Combination therapy); Route of administration (Oral, Inhaled, Intravenous, Subcutaneous) and Geography
Report Code: TIPRE00004065 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Asthma is a chronic disease which shows various symptoms such as coughing, wheezing, chest tightness and breath shortness. Asthma is caused by environmental and genetic factors. The environmental factors include exposure to air pollution, pollen grains and allergens. The pulmonary airway muscles get swollen due to allergens, which cause bronchospasm and airway obstruction. Patients with genetic history of asthma are more prone to developing asthma. Asthma can be controlled by early asthma treatment. The medications include long acting beta-agonists (LABA), corticosteroids, anti-inflammatory agents and leukotriene modifiers. Asthma patients are always at risk of developing with pneumonia and influenza. Asthma mimicking symptoms have been found in a host of diseases in children. Hence, diagnosis and treatment of asthma in children has remained a challenge.
According to the Global Initiative for Asthma (GINA), in 2013, 300 million patients globally were reported to be afflicted with asthma and the number is expected to grow in the coming years.
MARKET DYNAMICS
Increasing amount of pollution especially children making their immune system weak and sensitive, growing number of smokers and frequent lifestyle changes are the major driving factors for asthma therapeutics market. Thus, various governments are taking initiatives to create awareness amongst people about asthma and related diseases.
MARKET SCOPE
The "Global Asthma Therapeutics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Asthma therapeutics market with detailed market segmentation by product type, drug class, route of administration and geography. The global asthma therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Asthma therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global asthma therapeutics market is segmented on the basis of product type, drug class and route of administration. Based on products type, the market is segmented as dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer. On the basis of drug class, the global asthma therapeutics market is segmented into anti-inflammatory drugs, bronchodilators and combination therapy. Based on route of administration, the market segmented into oral, inhaled, intravenous and subcutaneous.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global asthma therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The asthma therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Asthma therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Asthma therapeutics market in these regions.
MARKET PLAYERS
The reports cover key developments in the Asthma therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Asthma therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for Asthma therapeutics in the global market. Below mentioned is the list of few companies engaged in the Asthma therapeutics market.
The report also includes the profiles of key Asthma therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Asthma is a chronic disease which shows various symptoms such as coughing, wheezing, chest tightness and breath shortness. Asthma is caused by environmental and genetic factors. The environmental factors include exposure to air pollution, pollen grains and allergens. The pulmonary airway muscles get swollen due to allergens, which cause bronchospasm and airway obstruction. Patients with genetic history of asthma are more prone to developing asthma. Asthma can be controlled by early asthma treatment. The medications include long acting beta-agonists (LABA), corticosteroids, anti-inflammatory agents and leukotriene modifiers. Asthma patients are always at risk of developing with pneumonia and influenza. Asthma mimicking symptoms have been found in a host of diseases in children. Hence, diagnosis and treatment of asthma in children has remained a challenge.
According to the Global Initiative for Asthma (GINA), in 2013, 300 million patients globally were reported to be afflicted with asthma and the number is expected to grow in the coming years.
MARKET DYNAMICS
Increasing amount of pollution especially children making their immune system weak and sensitive, growing number of smokers and frequent lifestyle changes are the major driving factors for asthma therapeutics market. Thus, various governments are taking initiatives to create awareness amongst people about asthma and related diseases.
MARKET SCOPE
The "Global Asthma Therapeutics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Asthma therapeutics market with detailed market segmentation by product type, drug class, route of administration and geography. The global asthma therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Asthma therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global asthma therapeutics market is segmented on the basis of product type, drug class and route of administration. Based on products type, the market is segmented as dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer. On the basis of drug class, the global asthma therapeutics market is segmented into anti-inflammatory drugs, bronchodilators and combination therapy. Based on route of administration, the market segmented into oral, inhaled, intravenous and subcutaneous.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global asthma therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The asthma therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Asthma therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Asthma therapeutics market in these regions.
The reports cover key developments in the Asthma therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Asthma therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for Asthma therapeutics in the global market. Below mentioned is the list of few companies engaged in the Asthma therapeutics market.
The report also includes the profiles of key Asthma therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- F. Hoffmann-La Roche Ltd.
- Amgen, Inc.
- Abbott Laboratories
- Johnson & Johnson
- Novartis AG
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- Eli Lilly and Company
- Pfizer Inc.
- Biogen Inc.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Asthma Therapeutics Market - By Product Type
1.3.2 Asthma Therapeutics Market - By Drug Class
1.3.3 Asthma Therapeutics Market - By Route of administration
1.3.4 Asthma Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ASTHMA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ASTHMA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ASTHMA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ASTHMA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ASTHMA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRY POWDER INHALERS
7.3.1. Overview
7.3.2. Dry powder inhalers Market Forecast and Analysis
7.4. METERED DOSE INHALERS
7.4.1. Overview
7.4.2. Metered dose inhalers Market Forecast and Analysis
7.5. MIST INHALERS
7.5.1. Overview
7.5.2. Mist inhalers Market Forecast and Analysis
7.6. NEBULIZER
7.6.1. Overview
7.6.2. Nebulizer Market Forecast and Analysis
8. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. ANTI-INFLAMMATORY DRUGS
8.3.1. Overview
8.3.2. Anti-inflammatory drugs Market Forecast and Analysis
8.4. BRONCHODILATORS
8.4.1. Overview
8.4.2. Bronchodilators Market Forecast and Analysis
8.5. COMBINATION THERAPY
8.5.1. Overview
8.5.2. Combination therapy Market Forecast and Analysis
9. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INHALED
9.4.1. Overview
9.4.2. Inhaled Market Forecast and Analysis
9.5. INTRAVENOUS
9.5.1. Overview
9.5.2. Intravenous Market Forecast and Analysis
9.6. SUBCUTANEOUS
9.6.1. Overview
9.6.2. Subcutaneous Market Forecast and Analysis
10. ASTHMA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Asthma Therapeutics Market Overview
10.1.2 North America Asthma Therapeutics Market Forecasts and Analysis
10.1.3 North America Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.1.4 North America Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.1.5 North America Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.1.6 North America Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Asthma Therapeutics Market
10.1.6.1.1 United States Asthma Therapeutics Market by Product Type
10.1.6.1.2 United States Asthma Therapeutics Market by Drug Class
10.1.6.1.3 United States Asthma Therapeutics Market by Route of administration
10.1.6.2 Canada Asthma Therapeutics Market
10.1.6.2.1 Canada Asthma Therapeutics Market by Product Type
10.1.6.2.2 Canada Asthma Therapeutics Market by Drug Class
10.1.6.2.3 Canada Asthma Therapeutics Market by Route of administration
10.1.6.3 Mexico Asthma Therapeutics Market
10.1.6.3.1 Mexico Asthma Therapeutics Market by Product Type
10.1.6.3.2 Mexico Asthma Therapeutics Market by Drug Class
10.1.6.3.3 Mexico Asthma Therapeutics Market by Route of administration
10.2. EUROPE
10.2.1 Europe Asthma Therapeutics Market Overview
10.2.2 Europe Asthma Therapeutics Market Forecasts and Analysis
10.2.3 Europe Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.2.4 Europe Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.2.5 Europe Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.2.6 Europe Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Asthma Therapeutics Market
10.2.6.1.1 Germany Asthma Therapeutics Market by Product Type
10.2.6.1.2 Germany Asthma Therapeutics Market by Drug Class
10.2.6.1.3 Germany Asthma Therapeutics Market by Route of administration
10.2.6.2 France Asthma Therapeutics Market
10.2.6.2.1 France Asthma Therapeutics Market by Product Type
10.2.6.2.2 France Asthma Therapeutics Market by Drug Class
10.2.6.2.3 France Asthma Therapeutics Market by Route of administration
10.2.6.3 Italy Asthma Therapeutics Market
10.2.6.3.1 Italy Asthma Therapeutics Market by Product Type
10.2.6.3.2 Italy Asthma Therapeutics Market by Drug Class
10.2.6.3.3 Italy Asthma Therapeutics Market by Route of administration
10.2.6.4 Spain Asthma Therapeutics Market
10.2.6.4.1 Spain Asthma Therapeutics Market by Product Type
10.2.6.4.2 Spain Asthma Therapeutics Market by Drug Class
10.2.6.4.3 Spain Asthma Therapeutics Market by Route of administration
10.2.6.5 United Kingdom Asthma Therapeutics Market
10.2.6.5.1 United Kingdom Asthma Therapeutics Market by Product Type
10.2.6.5.2 United Kingdom Asthma Therapeutics Market by Drug Class
10.2.6.5.3 United Kingdom Asthma Therapeutics Market by Route of administration
10.2.6.6 Rest of Europe Asthma Therapeutics Market
10.2.6.6.1 Rest of Europe Asthma Therapeutics Market by Product Type
10.2.6.6.2 Rest of Europe Asthma Therapeutics Market by Drug Class
10.2.6.6.3 Rest of Europe Asthma Therapeutics Market by Route of administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Asthma Therapeutics Market Overview
10.3.2 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.3.5 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.3.6 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Asthma Therapeutics Market
10.3.6.1.1 Australia Asthma Therapeutics Market by Product Type
10.3.6.1.2 Australia Asthma Therapeutics Market by Drug Class
10.3.6.1.3 Australia Asthma Therapeutics Market by Route of administration
10.3.6.2 China Asthma Therapeutics Market
10.3.6.2.1 China Asthma Therapeutics Market by Product Type
10.3.6.2.2 China Asthma Therapeutics Market by Drug Class
10.3.6.2.3 China Asthma Therapeutics Market by Route of administration
10.3.6.3 India Asthma Therapeutics Market
10.3.6.3.1 India Asthma Therapeutics Market by Product Type
10.3.6.3.2 India Asthma Therapeutics Market by Drug Class
10.3.6.3.3 India Asthma Therapeutics Market by Route of administration
10.3.6.4 Japan Asthma Therapeutics Market
10.3.6.4.1 Japan Asthma Therapeutics Market by Product Type
10.3.6.4.2 Japan Asthma Therapeutics Market by Drug Class
10.3.6.4.3 Japan Asthma Therapeutics Market by Route of administration
10.3.6.5 South Korea Asthma Therapeutics Market
10.3.6.5.1 South Korea Asthma Therapeutics Market by Product Type
10.3.6.5.2 South Korea Asthma Therapeutics Market by Drug Class
10.3.6.5.3 South Korea Asthma Therapeutics Market by Route of administration
10.3.6.6 Rest of Asia-Pacific Asthma Therapeutics Market
10.3.6.6.1 Rest of Asia-Pacific Asthma Therapeutics Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Asthma Therapeutics Market by Drug Class
10.3.6.6.3 Rest of Asia-Pacific Asthma Therapeutics Market by Route of administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Asthma Therapeutics Market Overview
10.4.2 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.4.5 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.4.6 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Asthma Therapeutics Market
10.4.6.1.1 South Africa Asthma Therapeutics Market by Product Type
10.4.6.1.2 South Africa Asthma Therapeutics Market by Drug Class
10.4.6.1.3 South Africa Asthma Therapeutics Market by Route of administration
10.4.6.2 Saudi Arabia Asthma Therapeutics Market
10.4.6.2.1 Saudi Arabia Asthma Therapeutics Market by Product Type
10.4.6.2.2 Saudi Arabia Asthma Therapeutics Market by Drug Class
10.4.6.2.3 Saudi Arabia Asthma Therapeutics Market by Route of administration
10.4.6.3 U.A.E Asthma Therapeutics Market
10.4.6.3.1 U.A.E Asthma Therapeutics Market by Product Type
10.4.6.3.2 U.A.E Asthma Therapeutics Market by Drug Class
10.4.6.3.3 U.A.E Asthma Therapeutics Market by Route of administration
10.4.6.4 Rest of Middle East and Africa Asthma Therapeutics Market
10.4.6.4.1 Rest of Middle East and Africa Asthma Therapeutics Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Asthma Therapeutics Market by Drug Class
10.4.6.4.3 Rest of Middle East and Africa Asthma Therapeutics Market by Route of administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Asthma Therapeutics Market Overview
10.5.2 South and Central America Asthma Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.5.5 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.5.6 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Asthma Therapeutics Market
10.5.6.1.1 Brazil Asthma Therapeutics Market by Product Type
10.5.6.1.2 Brazil Asthma Therapeutics Market by Drug Class
10.5.6.1.3 Brazil Asthma Therapeutics Market by Route of administration
10.5.6.2 Argentina Asthma Therapeutics Market
10.5.6.2.1 Argentina Asthma Therapeutics Market by Product Type
10.5.6.2.2 Argentina Asthma Therapeutics Market by Drug Class
10.5.6.2.3 Argentina Asthma Therapeutics Market by Route of administration
10.5.6.3 Rest of South and Central America Asthma Therapeutics Market
10.5.6.3.1 Rest of South and Central America Asthma Therapeutics Market by Product Type
10.5.6.3.2 Rest of South and Central America Asthma Therapeutics Market by Drug Class
10.5.6.3.3 Rest of South and Central America Asthma Therapeutics Market by Route of administration
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ASTHMA THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. PHILIPS HEALTHCARE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM GMBH
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SANOFI-AVENTIS SA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CAREFUSION CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SUNOVION PHARMACEUTICALS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK AND CO., INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ROCHE DIAGNOSTICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Asthma Therapeutics Market - By Product Type
1.3.2 Asthma Therapeutics Market - By Drug Class
1.3.3 Asthma Therapeutics Market - By Route of administration
1.3.4 Asthma Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ASTHMA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ASTHMA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ASTHMA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ASTHMA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ASTHMA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRY POWDER INHALERS
7.3.1. Overview
7.3.2. Dry powder inhalers Market Forecast and Analysis
7.4. METERED DOSE INHALERS
7.4.1. Overview
7.4.2. Metered dose inhalers Market Forecast and Analysis
7.5. MIST INHALERS
7.5.1. Overview
7.5.2. Mist inhalers Market Forecast and Analysis
7.6. NEBULIZER
7.6.1. Overview
7.6.2. Nebulizer Market Forecast and Analysis
8. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. ANTI-INFLAMMATORY DRUGS
8.3.1. Overview
8.3.2. Anti-inflammatory drugs Market Forecast and Analysis
8.4. BRONCHODILATORS
8.4.1. Overview
8.4.2. Bronchodilators Market Forecast and Analysis
8.5. COMBINATION THERAPY
8.5.1. Overview
8.5.2. Combination therapy Market Forecast and Analysis
9. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INHALED
9.4.1. Overview
9.4.2. Inhaled Market Forecast and Analysis
9.5. INTRAVENOUS
9.5.1. Overview
9.5.2. Intravenous Market Forecast and Analysis
9.6. SUBCUTANEOUS
9.6.1. Overview
9.6.2. Subcutaneous Market Forecast and Analysis
10. ASTHMA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Asthma Therapeutics Market Overview
10.1.2 North America Asthma Therapeutics Market Forecasts and Analysis
10.1.3 North America Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.1.4 North America Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.1.5 North America Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.1.6 North America Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Asthma Therapeutics Market
10.1.6.1.1 United States Asthma Therapeutics Market by Product Type
10.1.6.1.2 United States Asthma Therapeutics Market by Drug Class
10.1.6.1.3 United States Asthma Therapeutics Market by Route of administration
10.1.6.2 Canada Asthma Therapeutics Market
10.1.6.2.1 Canada Asthma Therapeutics Market by Product Type
10.1.6.2.2 Canada Asthma Therapeutics Market by Drug Class
10.1.6.2.3 Canada Asthma Therapeutics Market by Route of administration
10.1.6.3 Mexico Asthma Therapeutics Market
10.1.6.3.1 Mexico Asthma Therapeutics Market by Product Type
10.1.6.3.2 Mexico Asthma Therapeutics Market by Drug Class
10.1.6.3.3 Mexico Asthma Therapeutics Market by Route of administration
10.2. EUROPE
10.2.1 Europe Asthma Therapeutics Market Overview
10.2.2 Europe Asthma Therapeutics Market Forecasts and Analysis
10.2.3 Europe Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.2.4 Europe Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.2.5 Europe Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.2.6 Europe Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Asthma Therapeutics Market
10.2.6.1.1 Germany Asthma Therapeutics Market by Product Type
10.2.6.1.2 Germany Asthma Therapeutics Market by Drug Class
10.2.6.1.3 Germany Asthma Therapeutics Market by Route of administration
10.2.6.2 France Asthma Therapeutics Market
10.2.6.2.1 France Asthma Therapeutics Market by Product Type
10.2.6.2.2 France Asthma Therapeutics Market by Drug Class
10.2.6.2.3 France Asthma Therapeutics Market by Route of administration
10.2.6.3 Italy Asthma Therapeutics Market
10.2.6.3.1 Italy Asthma Therapeutics Market by Product Type
10.2.6.3.2 Italy Asthma Therapeutics Market by Drug Class
10.2.6.3.3 Italy Asthma Therapeutics Market by Route of administration
10.2.6.4 Spain Asthma Therapeutics Market
10.2.6.4.1 Spain Asthma Therapeutics Market by Product Type
10.2.6.4.2 Spain Asthma Therapeutics Market by Drug Class
10.2.6.4.3 Spain Asthma Therapeutics Market by Route of administration
10.2.6.5 United Kingdom Asthma Therapeutics Market
10.2.6.5.1 United Kingdom Asthma Therapeutics Market by Product Type
10.2.6.5.2 United Kingdom Asthma Therapeutics Market by Drug Class
10.2.6.5.3 United Kingdom Asthma Therapeutics Market by Route of administration
10.2.6.6 Rest of Europe Asthma Therapeutics Market
10.2.6.6.1 Rest of Europe Asthma Therapeutics Market by Product Type
10.2.6.6.2 Rest of Europe Asthma Therapeutics Market by Drug Class
10.2.6.6.3 Rest of Europe Asthma Therapeutics Market by Route of administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Asthma Therapeutics Market Overview
10.3.2 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.3.5 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.3.6 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Asthma Therapeutics Market
10.3.6.1.1 Australia Asthma Therapeutics Market by Product Type
10.3.6.1.2 Australia Asthma Therapeutics Market by Drug Class
10.3.6.1.3 Australia Asthma Therapeutics Market by Route of administration
10.3.6.2 China Asthma Therapeutics Market
10.3.6.2.1 China Asthma Therapeutics Market by Product Type
10.3.6.2.2 China Asthma Therapeutics Market by Drug Class
10.3.6.2.3 China Asthma Therapeutics Market by Route of administration
10.3.6.3 India Asthma Therapeutics Market
10.3.6.3.1 India Asthma Therapeutics Market by Product Type
10.3.6.3.2 India Asthma Therapeutics Market by Drug Class
10.3.6.3.3 India Asthma Therapeutics Market by Route of administration
10.3.6.4 Japan Asthma Therapeutics Market
10.3.6.4.1 Japan Asthma Therapeutics Market by Product Type
10.3.6.4.2 Japan Asthma Therapeutics Market by Drug Class
10.3.6.4.3 Japan Asthma Therapeutics Market by Route of administration
10.3.6.5 South Korea Asthma Therapeutics Market
10.3.6.5.1 South Korea Asthma Therapeutics Market by Product Type
10.3.6.5.2 South Korea Asthma Therapeutics Market by Drug Class
10.3.6.5.3 South Korea Asthma Therapeutics Market by Route of administration
10.3.6.6 Rest of Asia-Pacific Asthma Therapeutics Market
10.3.6.6.1 Rest of Asia-Pacific Asthma Therapeutics Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Asthma Therapeutics Market by Drug Class
10.3.6.6.3 Rest of Asia-Pacific Asthma Therapeutics Market by Route of administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Asthma Therapeutics Market Overview
10.4.2 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.4.5 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.4.6 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Asthma Therapeutics Market
10.4.6.1.1 South Africa Asthma Therapeutics Market by Product Type
10.4.6.1.2 South Africa Asthma Therapeutics Market by Drug Class
10.4.6.1.3 South Africa Asthma Therapeutics Market by Route of administration
10.4.6.2 Saudi Arabia Asthma Therapeutics Market
10.4.6.2.1 Saudi Arabia Asthma Therapeutics Market by Product Type
10.4.6.2.2 Saudi Arabia Asthma Therapeutics Market by Drug Class
10.4.6.2.3 Saudi Arabia Asthma Therapeutics Market by Route of administration
10.4.6.3 U.A.E Asthma Therapeutics Market
10.4.6.3.1 U.A.E Asthma Therapeutics Market by Product Type
10.4.6.3.2 U.A.E Asthma Therapeutics Market by Drug Class
10.4.6.3.3 U.A.E Asthma Therapeutics Market by Route of administration
10.4.6.4 Rest of Middle East and Africa Asthma Therapeutics Market
10.4.6.4.1 Rest of Middle East and Africa Asthma Therapeutics Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Asthma Therapeutics Market by Drug Class
10.4.6.4.3 Rest of Middle East and Africa Asthma Therapeutics Market by Route of administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Asthma Therapeutics Market Overview
10.5.2 South and Central America Asthma Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
10.5.5 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
10.5.6 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Asthma Therapeutics Market
10.5.6.1.1 Brazil Asthma Therapeutics Market by Product Type
10.5.6.1.2 Brazil Asthma Therapeutics Market by Drug Class
10.5.6.1.3 Brazil Asthma Therapeutics Market by Route of administration
10.5.6.2 Argentina Asthma Therapeutics Market
10.5.6.2.1 Argentina Asthma Therapeutics Market by Product Type
10.5.6.2.2 Argentina Asthma Therapeutics Market by Drug Class
10.5.6.2.3 Argentina Asthma Therapeutics Market by Route of administration
10.5.6.3 Rest of South and Central America Asthma Therapeutics Market
10.5.6.3.1 Rest of South and Central America Asthma Therapeutics Market by Product Type
10.5.6.3.2 Rest of South and Central America Asthma Therapeutics Market by Drug Class
10.5.6.3.3 Rest of South and Central America Asthma Therapeutics Market by Route of administration
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ASTHMA THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. PHILIPS HEALTHCARE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM GMBH
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SANOFI-AVENTIS SA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CAREFUSION CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SUNOVION PHARMACEUTICALS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK AND CO., INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ROCHE DIAGNOSTICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Philips Healthcare
2. AstraZeneca Plc.
3. GlaxoSmithKline Plc.
4. Teva Pharmaceutical Industries Ltd.
5. Boehringer Ingelheim GmbH
6. Sanofi-Aventis SA
7. CareFusion Corporation
8. Sunovion Pharmaceuticals, Inc.
9. Merck & Co., Inc.
10. Roche Diagnostics
1. Philips Healthcare
2. AstraZeneca Plc.
3. GlaxoSmithKline Plc.
4. Teva Pharmaceutical Industries Ltd.
5. Boehringer Ingelheim GmbH
6. Sanofi-Aventis SA
7. CareFusion Corporation
8. Sunovion Pharmaceuticals, Inc.
9. Merck & Co., Inc.
10. Roche Diagnostics